These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31705563)

  • 1. Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee.
    Ipe TS; Raval JS; Fernando LP; Gokhale A; Jacquot C; Johnson AD; Kim HC; Monis GF; Mo YD; Morgan SM; Pagano MB; Pham HP; Sanford K; Schmidt AE; Schwartz J; Waldman A; Webb J; Winters JL; Wu Y; Yamada C; Wong ECC
    J Clin Apher; 2020 Jan; 35(1):25-32. PubMed ID: 31705563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders-Experience from Tertiary Care Center in North India.
    Hans R; Prakash S; Sharma RR; Sankhyan N; Takkar A; Goyal M; Saikia B; Lal V; Marwaha N
    Neurol India; 2022; 70(2):710-713. PubMed ID: 35532644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders and Related Disorders in Resource-Limited Settings: Outcomes in a Multiethnic Single-Center Population.
    Ong ZM; Schee JP; Viswanathan S
    Ther Apher Dial; 2020 Jun; 24(3):312-323. PubMed ID: 31654607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic plasma exchange in neuromyelitis optica: a case series.
    Morgan SM; Zantek ND; Carpenter AF
    J Clin Apher; 2014 Jun; 29(3):171-7. PubMed ID: 24136389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders.
    Gonzalez C; Vargas D; Contreras K; Garcia P; Rodriguez P; Zarco L; Navas C
    Ther Apher Dial; 2022 Dec; 26(6):1274-1280. PubMed ID: 35353437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein spectrum changes in exosomes after therapeutic plasma exchange in patients with neuromyelitis optica.
    Ma C; Wang S; Wang G; Wu Y; Yang T; Shen W; Zhuang Y; Zhang L; Liu X; Yang L; Feng Y; Yu Y; Liu Z; Wang D
    J Clin Apher; 2020 Jun; 35(3):206-216. PubMed ID: 32240559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential intermittent therapeutic plasma exchange: A possible induction and maintenance therapy in the management of adult patients with neuromyelitis optica spectrum disorder.
    Viswanathan S; Schee JP; Omar MA; Hiew FL
    Ther Apher Dial; 2021 Aug; 25(4):513-532. PubMed ID: 33029928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of therapeutic apheresis in patients with refractory neuromyelitis optica spectrum disorders: a single-center retrospective study.
    Zhang L; Zhuang Y; Liu X; Xu Q; Zhou L; Zou L; Jiang Y; Tian J; Yao H; Chi H; Qiu X; Yang T; Wang D; Yu Y
    Ann Palliat Med; 2021 Mar; 10(3):3105-3114. PubMed ID: 33752428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the ASFA apheresis registry study on Wilson's disease.
    Pham HP; Schwartz J; Cooling L; Hofmann JC; Kim HC; Morgan S; Pagano MB; Schneiderman J; Winters JL; Yamada C; Wong EC; Wu Y
    J Clin Apher; 2016 Feb; 31(1):11-5. PubMed ID: 26275240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility & safety of plasma exchange in paediatric neuro-immunology: A single center experience.
    Shah YD; Eksambe P; Fomani K; Louie J; Shefali K; Kothare S
    Eur J Paediatr Neurol; 2020 Jul; 27():94-97. PubMed ID: 32307218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination.
    Savransky A; Rubstein A; Rios MH; Vergel SL; Velasquez MC; Sierra SP; Marcarian G; Alba R; Pugliese AM; Tenembaum S
    Neurology; 2019 Nov; 93(22):e2065-e2073. PubMed ID: 31645471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of the ASFA apheresis registry on muscle specific kinase antibody positive myasthenia gravis.
    Yamada C; Pham HP; Wu Y; Cooling L; Kim HC; Morgan S; Schwartz J; Winters JL; Wong EC
    J Clin Apher; 2017 Feb; 32(1):5-11. PubMed ID: 26946363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurologic indications for therapeutic plasma exchange: an update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urgent therapeutic plasma exchange.
    Saheb S; Gallo A
    Transfus Apher Sci; 2020 Dec; 59(6):102991. PubMed ID: 33221122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Exchange for Neuromyelitis Optica Spectrum Disorders in Chinese Patients and Factors Predictive of Short-term Outcome.
    Jiao Y; Cui L; Zhang W; Zhang Y; Wang W; Zhang L; Tang W; Jiao J
    Clin Ther; 2018 Apr; 40(4):603-612. PubMed ID: 29606515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange for neuromyelitis optica attacks: Evidence and challenges from a real-world cohort from Brazil.
    de Almeida GMR; de Araujo RS; Castrillo BB; Silva GD; Fortini I; Gonçalves MRR; Castro LHM; Tatsui NH; Adoni T; Sato DK; Apóstolos-Pereira SL; Callegaro D
    J Neuroimmunol; 2024 Mar; 388():578295. PubMed ID: 38280268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders.
    Lim YM; Pyun SY; Kang BH; Kim J; Kim KK
    Mult Scler; 2013 Aug; 19(9):1216-8. PubMed ID: 23263897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
    Kaya E; Keklik M; Sencan M; Yilmaz M; Keskin A; Kiki I; Erkurt MA; Sivgin S; Korkmaz S; Okan V; Doğu MH; Unal A; Cetin M; Altuntaş F; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of therapeutic plasma exchange by using apheresis devices in pediatric atypical hemolytic uremic syndrome patients.
    Hans R; Sharma RR; Marwaha N; Suri D; Kumar R; Gupta A; Singh S
    J Clin Apher; 2016 Aug; 31(4):381-7. PubMed ID: 26212115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders.
    Mori S; Kurimoto T; Ueda K; Nakamura M
    Jpn J Ophthalmol; 2018 Jul; 62(4):525-530. PubMed ID: 29802557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.